Global News

BIND Therapeutics, Roche collaborate on discovery of novel nanomedicines

Friday, June 20, 2014 12:07 PM

BIND Therapeutics, a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins, has entered into a research agreement with Roche to discover novel nanomedicines using Accurins for the treatment of diseases in therapeutic areas outside of oncology. The collaboration will focus on combining BIND's Accurin technology with Roche's proprietary therapeutic payloads and targeting ligands.

More... »

WIRB Copernicus Group

Kibow Biotech is a "Buzz of BIO" award winner

Thursday, June 19, 2014 02:52 PM

Kibow Biotech is winner of a 2014 BIO International Convention "Buzz of BIO Award," and is the first biotechnology company specializing exclusively in dietary supplement products to receive the honor during BIO's 29-year history. BIO is the world's largest trade association, representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the U.S. and more than 30 other nations. BIO member companies are involved in the R&D of innovative healthcare, agricultural, industrial and environmental biotechnology products.

More... »

CRF Health eCOA webinar series

Bellerophon completes enrollment for phase II trial of INOpulse for PAH

Thursday, June 19, 2014 02:46 PM

Bellerophon Therapeutics, a clinical stage biotherapeutics company has completed enrollment of its 80-patient phase II clinical trial of INOpulse for the treatment of pulmonary arterial hypertension (PAH). PAH is a life-threatening, progressive disorder characterized by abnormal constriction of the arteries of the lung, leading to increased blood pressure in the lungs and abnormal strain on the heart's right ventricle, eventually leading to heart failure.

More... »

Sorbent Therapeutics appoints two new board members

Thursday, June 19, 2014 02:27 PM

Sorbent Therapeutics, a biopharmaceutical company developing therapies for cardiovascular and renal diseases, has appointed Jay Shepard and William D. Waddill to the company's board of directors.

More... »

Debiopharm Group initiates phase I study of Debio 1450 for staphylococcal infections

Thursday, June 19, 2014 02:16 PM

Debiopharm Group, a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs as well as companion diagnostics, has launched a phase I dose-escalation study of Debio 1450 (previously known as AFN-1720), a highly potent anti-infective agent that is selectively active against a large number of Staphylococcus species, including all known resistant strains such as methicillin-resistant S. aureus (MRSA) and vancomycin-intermediate S. aureus (VISA).

More... »

Sangamo BioSciences appoints H. Stewart Parker to its board of directors

Thursday, June 19, 2014 01:57 PM

Sangamo BioSciences announced the appointment of H. Stewart Parker to the company's board of directors. Parker, who founded and was president and CEO of Targeted Genetics, brings more than 30 years of experience in the biotechnology industry, including 16 years of specific experience in cell and gene therapy.

More... »

Recipharm, CTC form new collaboration

Thursday, June 19, 2014 01:49 PM

CTC Clinical Trial Consultants and Recipharm Pharmaceutical Development have entered into a collaboration.

More... »

Exco InTouch, AstraZeneca mHealth collaboration produces Me&MyCOPD

Thursday, June 19, 2014 01:38 PM

Exco InTouch, a provider of digital patient engagement and data capture solutions for healthcare providers, said its collaboration with AstraZeneca has led to the development of an mHealth program Me&MyCOPD ,which improves condition management for patients suffering from chronic obstructive pulmonary disease (COPD), as well as for their caregivers and healthcare providers.

More... »

SWHR supports legislation to study sex differences, get more women in trials

Wednesday, June 18, 2014 01:03 PM

The Society for Women’s Health Research (SWHR) endorses the Research for All Act of 2014, introduced by U.S. Representatives Jim Cooper (D-TN) and Cynthia Lummis (R-WY). SWHR believes this legislation will have a powerful impact on women’s health research.

More... »

ERT launches updated diagnostic platform for respiratory clinical trials

Wednesday, June 18, 2014 01:01 PM

ERT, a global solution provider for high-quality patient safety and efficacy endpoint data collection, has launched MasterScope2.0, a new, comprehensive platform for spirometry, ECG and home monitoring. Especially designed for standardized and centralized clinical trials, MasterScope 2.0 delivers an all-in-one solution that meets the data collection and processing needs of worldwide clinical trial sponsors in the development of medical treatments for respiratory conditions.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

July 28

WCG acquires Alliance Biosciences to expand its biosafety oversight capabilities, ensure compliance

Facilitated review meetings for protocol design catching on, decreasing amendments, complexity

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

CRO market poised for growth and consolidation
Sponsors expanding pipelines, shrinking infrastructure fuel strategic outsourcing

Strategies for success evolving in phase I space
Sites see increasing complexity, more patients, greater focus on efficacy

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs